Pennant Investors »

Arcutis Biotherapeutics shares owned by Pennant Investors

Quarter-by-quarter ownership of Arcutis Biotherapeutics (ARQT) shares owned by Pennant Investors from 13F filings

Historical chart of Pennant Investors investment in Arcutis Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Arcutis Biotherapeutics held by Pennant Investors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arcutis Biotherapeutics by Pennant Investors

Quarter filed Position value Share count Share price at filing
2024-03-31 $1.7M 171k 9.91

More positions owned by Pennant Investors

Amazon (AMZN)
TransDigm Group Incorporated (TDG)
Antero Res Call Option (AR)
Microsoft Corporation (MSFT)
Micron Technology (MU)
Echostar Corp Cl A (SATS)
Alphabet Cap Stk Cl A (GOOGL)
Apple Put Option (AAPL)
Colfax Corp (ENOV)
ODP Corp. (ODP)
Perimeter Solutions Sa Common Stock (PRM)
Fibrogen (FGEN)
Arcutis Biotherapeutics (ARQT)
Altimmune Com New (ALT)
Fate Therapeutics (FATE)

View all positions for Pennant Investors

Top funds holding Arcutis Biotherapeutics

Jennison Associates
Frazier Life Sciences Management
State Street Corporation
Suvretta Capital Management
Rubric Capital Management
Polar Capital Holdings
BlackRock
Vanguard Group
Franklin Resources
Gilder, Gagnon, Howe & Co
Morgan Stanley
Ensign Peak Advisors
Citadel Advisors
Cormorant Asset Management
Pivotal bioVenture Partners Investment Advisor

View all funds holding Arcutis Biotherapeutics